4/A

FORM 4/A SUBMISSION

Company: Phathom Pharmaceuticals, Inc.
Filed: July 21, 2023
Period of Report: July 14, 2023
Accession Number: 0001209191-23-043162

View Document ↗ View on SEC.gov ↗